AVEO Pharmaceuticals Overview

AVEO Pharmaceuticals EBIT

EBIT (Earnings Before Interest and Taxes) analysis for AVEO.

Quarterly EBIT

-$2.17M

↑ 76.47% YoY

As of Sep 30, 2022

Annual EBIT (TTM)

-$24.49M

↑ 56.33% YoY

Trailing 12 months ending Sep 30, 2022

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin